To understand chronic neutrophil attraction into cystic fibrosis airways, both global chemotactic activity and individual chemotactic factors were studied in bronchial secretions. Bronchial secretions of 8 cystic fibrosis patients, collected on the first day of admission for antibiotic treatment, showed a high chemotactic index (19.4 { 5.7, n Å 8). Fractionation by gel filtration of bronchial secretions resulted in three chemotactic fractions. The first factor corresponded to interleukin-8, and the second activated neutrophils via the FMLP receptor. The third factor, which was of lower molecular weight, did not activate FMLP or leukotriene B 4 receptors, and its nature is still under investigation. Treating patients with antibiotics reduced global chemotactic activity, mainly by reducing the activity due to stimulation of the FMLP receptor.
Patients with cystic fibrosis (CF) suffer from a progressively intravenous antibiotic treatment was shown to decrease the concentration of bacterial pathogens in bronchial secretions destructive bronchitis that leads to respiratory failure. Chronic infection is characterized by airway colonization with bacteria and to decrease the number of inflammatory cells [9] , the chemotactic activity before and after intravenous antibiotic therapy (e.g., Haemophilus influenzae, Staphylococcus aureus, and Pseudomonas aeruginosa) totalling up to 10 9 -10 11 microorwas also studied. ganisms and by the presence of 10 8 neutrophils/mL of bronchial secretions [1, 2] .
Patients and Methods Since the damage to airway walls observed in CF is thought to be mainly mediated by neutrophil proteases [3, 4] , the identi- [5], interleukin (IL)-8 [6] , and leukotriene B 4 (LTB 4 ) [7] . Other Bronchial secretions. Bronchial secretions were collected over 24 h on the first and last days of antibiotic treatment. Sputum factors, such as bacterial chemotactic peptides and degradation samples were stored at 4ЊC during the collection period, weighed, products derived from the extracellular matrix protein elastin and processed as previously described [3] .
or from the complex between elastase and its inhibitor a1-Chemotactic activity. Chemotactic activity was determined by antiprotease [8] , are thought to be present. The relative impora modified Boyden chamber assay as described [10] . In a modifitance of these factors is not known, nor is it known which cation of this method, neutrophils were quantified by a viability factors are present simultaneously in bronchial secretions or test based on a colorimetric determination of the cleavage of how the levels of chemotactic factors in bronchial secretions at 37ЊC with 500 mM butyloxycarbonyl-methionyl-leucyl-phenyl- In the elution of the Sephadex G-75 column, the FMLP-like PBS at 4 mL/h, and 1-mL fractions were collected. Pools from the factors (pool B) were not well separated from pool C; thus, elution were concentrated by vacuum centrifugation and applied to the fractions corresponding to the two pools were combined a 1 1 120-cm Sephadex G-25 column, which was eluted with from three runs on Sephadex G-75, concentrated, and applied PBS at 10 mL/h. In separate runs, the columns were calibrated to a Sephadex G-25 column, in which they could be completely with molecular weight standards.
separated (not shown).

Statistical analysis. Samples from 8 patients were assessed
To confirm the results obtained with the bronchial secretions twice (before and after administration of antibiotics) as paired from 1 patient, it was necessary to investigate more samples.
samples by use of Wilcoxon's signed rank test. A t test for nonBronchial secretions collected at admission were subjected to paired samples was used where applicable for inhibition experichromatography on Sephadex G-75. When all elutions were ments. P õ .05 was considered significant. Values were expressed as mean { SE. compared, three major patterns emerged (figure 1A, 2A, and 2B). Three bronchial secretions contained no detectable chemotactic activity due to IL-8 or to FMLP, since all activity eluted at Results a position corresponding to pool C (figure 2A). Two bronchial secretions resolved their chemotactic activity into two peaks, Sputum samples that were collected from 8 patients at hospital admission were chemotactically active and showed a chemoone due to IL-8 and a second one corresponding to pool C in figures 1A and 2B. Three bronchial secretions contained all tactic index of 19.4 { 5.7. This activity was higher than the maximal chemotactic activity of strong chemotactic factors three chemotactic factors, as did the one shown in figure 1A .
No other chemotactic factors were detected in any of the samsuch as FMLP or IL-8 (not shown). Heating the samples to 95ЊC for 15 min allowed most of the proteins to coagulate and ples (not shown).
To evaluate the influence of antibiotic treatment, the chemoto destroy proteolytic activity, while chemotactic activity was not changed (not shown).
tactic activities before and after treatment were compared in one treatment course of each of the 8 patients. Global chemo-A sputum sample collected at admission from 1 of the 8 patients was precleared by heat treatment and centrifugation tactic activity decreased significantly from a chemotactic index of 19.4 { 2.0 to 11.4 { 1.3 (n Å 8, P Å .05) after treatment, and subjected to gel chromatography on Sephadex G-75. Figure  1A shows the elution pattern of this column. The large proteins which is still very high. IL-8 concentrations did not change significantly in the same time period (not shown). eluted in the void volume. IL-8 eluted in fractions 63 -70, while rhIL-8 eluted at fraction 63 ( figure 1A, arrow 4) . The
To determine the source of the decrease of the overall chemotactic activity after treatment, bronchial secretions collected first peak of chemotactic activity (pool A, figure 1A ) coeluted with IL-8 in fractions 63 -70. This activity was inhibited by a after each of the eight treatment courses were fractionated on Sephadex G-75. The results showed that antibiotic treatment monoclonal antibody directed against rhIL-8, as was that of rhIL-8, while the chemotactic activity of FMLP was not inhibreduced chemotactic activity mainly by lowering the amount of FMLP-like material in bronchial secretions. The activity ited ( figure 1B) .
The second chemotactic activity eluted in fractions 75 -104 corresponding to pool C remained unchanged. and was clearly separated from IL-8. It formed a plateau (fractions 75 -94, pool B) and a sharper peak at fractions 98 -104 Discussion (pool C). The factors constituting pool B and pool C seemed to be quite heterogeneous. The chemotactic activity of pool B
The high chemotactic activity of bronchial secretions is due to chemotactic factors that act together in neutrophil attraction. was inhibited by BocMLP, whereas that of the fractions of pool C was not ( figure 1A) . Since inhibition could be missed Since most known chemotactic factors have biphasic doseresponse relationships, the analysis of the relative importance when the concentration of the chemotactic factor is too high, as shown for FMLP at 1 mM ( figure 1C) , BocMLP inhibition of single factors in unfractionated bronchial secretions with specific inhibitors is unreliable or may even lead to false conwas tested on different concentrations of the chemotactic mate- figure 1A . A, Elution of bronchial secretion that contains only chemotactic activity corresponding to pool C ( figure 1A) . B, Elution of bronchial secretion that contains chemotactic activity due to interleukin (IL)-8 and corresponding to pool C. Neither sample contained detectable activity due to formyl-methionylleucyl-phenylalanine -like material. l Å chemotactic activity, ᭝ Å IL-8 as determined by ELISA, CI Å chemotactic index.
clusions. The fractionation proposed in this study revealed three
The chemotactic activity of pool C (figure 1A), although not completely separated on Sephadex G-75, could be sepamajor chemotactic factors in bronchial secretions. Their relative importance varied greatly when samples of bronchial secretions rated from pool B on Sephadex G-25. Its activity eluted like very small molecules and was due neither to FMLP-like from different patients were compared.
Since the activity of pool A was totally inhibited by antimaterial nor to IL-8 degradation products, and it was not due to LTB 4 ( figure 1 ). Future analysis will show whether IL-8 antibody (figure 1B), we concluded that this activity was entirely due to IL-8 and that no other chemotactic factor of the it is identical to one of the candidate chemotactic factors described, such as trinucleotides (ATP or UTP) [12] , fungal size of IL-8, such as C5a and GROa, was present after the elution.
products [13] , or oxidation products of lipids, such as 4-hydroxynonenal [14] . The chemotactic activity of pool B (figure 1A) was inhibited by BocMLP, a specific antagonist of the FMLP receptor. Since Antibiotic treatment was expected to reduce the level of FMLP-like bacterial products and, as a consequence of lowthis activity was spread over many fractions, both on Sephadex G-75 and on Sephadex G-25, it seemed to be very heterogeering infection, the level of IL-8. Samples collected before and after treatment showed that reducing the bacteria load neous in molecular size. Compared with the elution of FMLP, which eluted at a fraction corresponding to the end of the with antibiotics had an effect on the bacterial chemotactic factors (pool B) and to a small extent on IL-8 concentration elution of pool B from Sephadex G-25, the FMLP-like material was mostly composed of molecules larger than FMLP and (not shown). In contrast to our study, in which patients were not in exacerbation, Richman-Eisenstadt et al. [6] found a therefore very much resembled the chemotactins found in culture supernatants of Pseudomonas aeruginosa as described by decrease of IL-8 after antibiotic treatment in all of their 5 patients who were in exacerbation, suggesting that in an acute Fontan et al. [11] . It is thus likely that chemotactic factors from pool B are of bacterial origin. The fact that they were not found infection, IL-8 concentration was more susceptible to antibiotics. in all patients was surprising since all patients were colonized by Pseudomonas species (figure 2). Furthermore, the 4.2-kDa In summary, we have shown that by fractionation of bronchial secretions of CF patients with chronic airway inflammafragment of the a1-proteinase inhibitor, described as being chemotactic [8] , would also be found in pool B if present.
tion, three different chemotactic factors could be distinguished. This analysis may serve as a basis for future investigations of However, since almost all of the activity in pool B was inhibited by BocMLP, the fragment of the a1-proteinase inhibitor does therapeutic approaches aimed at lowering chemotactic activity in bronchial secretions and controlling inflammation and tissue not seem to be a major chemotactic factor in bronchial secretions.
destruction.
